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Abstract
Amniotic membranes (AMs) and corneas are critical materials in ocular surface 
reconstruction. AM has specific structures (e.g., basement and two types of cells 
with stemness characteristics: amniotic epithelial cells and amniotic mesenchymal 
cells), which contribute to its attractive physical and biological properties that make 
it fundamental to clinical application. The corneal endothelial cell is a vital part of 
the cornea, which can influence postoperative vision directly. However, widespread 
use of fresh AM and cornea has been limited due to their short use span and safety 
concerns. To overcome these concerns, different preservation methods have been 
introduced. Cryopreservation is distinguished from many preservation methods for 
its attractive advantages of prolonged use span, optimally retained tissue structure, 
and minimized infection risk. This review will focus on recent advances of cryo-
preserved AM and cornea, including different cryopreservation methods and their 
indications in ophthalmology.
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1. Cryopreservation of amniotic membranes
1.1 Introduction
Ever since Davis [1] first used human amniotic membrane (Figure 1) (AM) for 
skin transplantation, people have been exploring this remarkable biomaterial. AM is 
located in the innermost layer of the fetal membranes [2]. It is 0.02–0.05 mm thick, 
lightweight, elastic, almost transparent, and avascular membrane classically com-
posed of three layers: the epithelium, the basement membrane and the stroma layer 
[2]. There are two types of cells with stemness properties in AM: amniotic epithelial 
cells (AECs) and amniotic mesenchymal cells (AMSCs) [3], which are responsible 
for its unique biological properties including anti-inflammatory, anti-scarring, 
anti-microbial, angio-modulating, immunomodulatory, and anti-cancer effects 
[4–10]. Due to these properties, AM has become an ideal material for ocular recon-
struction including the treatment of persistent epithelial defects and non-healing 
corneal ulcers, corneal perforations and descemetoceles, bullous keratopathy, as 
well as corneal disorders with associated limbal stem cell deficiency, pterygium, 
conjunctival reconstruction, corneoscleral melts and perforations, and glaucoma 
surgeries. However, its use span is short and many viruses (such as HIV-1/2, hepati-
tis B, hepatitis C, human T-cell lymphotropic virus, syphilis, and cytomegalovirus) 
Cryopreservation - Current Advances and Evaluations
2
can be in their “window period” and escape detection, further limiting the use 
of fresh AM. To overcome these concerns, different preservation methods have 
emerged, such as freezing, lyophilization, and cryopreservation. However, most 
methods result in the destruction of endogenous cells and cause varying degrees 
of extracellular matrix (ECM) damage, which can affect the functionality of AM 
and its clinical benefits for wound treatment [11, 12]. Cryopreservation was first 
introduced by Lee and Tseng and has been proven to achieve high success rate in 
AM transplantation, which has been distinguished from many methods for its 
attractive advantages of prolonging use span, optimally retaining tissue structure, 
and minimizing infection risk [13, 14].
In this part, we classify the cryopreservation methods applied to amnion by 
commonly used cryoprotectant and analyze the influence of cryopreservation on 
AM combined with specific clinical trials.
1.2 General cryopreservation techniques
The AM is normally washed using balanced saline solution containing antibiot-
ics such as streptomycin, penicillin, neomycin, and amphotericin prior to storage. 
Pieces of AM resting on a carrier are placed in a vial containing cryoprotectant solu-
tion at a controlled cooling rate. Storage temperatures of −80°C are often utilized, 
with the maximum storage times ranging between 1 and 2 years [1, 11, 12].
The main disadvantage of cryopreservation is the requirement of a deep-
freezing facility, which is expensive, cumbersome, and frequently unavailable, 
especially in underdeveloped countries. In addition, maintaining stable storage 
temperatures during transportation is also relatively difficult.
1.3 Cryopreservation methods on AM
1.3.1 Glycerol-cryopreservation
Glycerol storage was first introduced in the Netherlands in 1984 to preserve 
donor skin for transplantation [13]. Positive results over subsequent decades 
have led to its clinical acceptance, including in the preservation of AM. Glycerol 
has led to higher cell viability and higher bFGF secretion for up to three 
months of AM storage [14]. After strict preservation and sterilization pro-
cesses, pieces of AM resting on a carrier are placed in a vial containing storage 
solution. Tseng’s laboratory introduced a methodology of glycerol (86%) in 
Dulbecco’s Modified Eagle Medium at a ratio of 1:1 [15, 16]. The most common 
Figure 1. 
Amniotic membrane (AM).
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cryopreservation protocol reported in the literature involves the use of 50% 
glycerol and storage at −80°C [17–21]. Undiluted and 98% glycerol have also 
been reported to be clinically effective [15].
In 2011, Thomasen et al. [21] showed that long-term storage of 50% glycerol 
cryopreserved AM for durations up to 24 months at −80°C did not significantly 
impair the histology of AM. Wagner et al. [14] used 85% glycerol for cryopre-
served AM, and their histological examinations had no significant alterations 
following cryopreservation, either for straight cryopreservation or with glycerol. 
They also demonstrated that neither tensile strength nor Young’s modulus was 
significantly influenced by the storage method. In addition, they also detected a 
significant increase in tensile strength over storage time, independent of the stor-
age method.
Some groups have found that storage of AM in 50% glycerol at −80°C decel-
lularizes the AM and results in low viability [17–20]. Interestingly, the results 
from Wagner et al. [14] research showed that epithelial cells were not significantly 
reduced during freezing in comparison to stromal cells, possibly indicating a higher 
sensitivity of stromal AM cells to freezing damage than epithelial cells (Figure 2). 
Through repeated measurement analysis, storage time showed a significant effect 
on cell viability. Prabhasawat et al. [22, 23] reported that the use of a highly con-
centrated glycerol solution abolishes AM cell viability. The possible toxic effect of 
glycerol is responsible for that.
To summarize, glycerol-cryopreserved AM retains the histological character-
istics of fresh AM independent of an increase in glycerol concentration. Tensile 
strength and elasticity can also be better preserved, with tensile strength increasing 
with storage time. However, the cell viability of cryopreserved AM was significantly 
affected by storage time and glycerol concentration. In particular, the stromal 
cells were more sensitive. A previous study [24] showed that this method had little 
effect on the growth factors of AM. More research is needed to confirm the effect of 
glycerol cryopreservation on AMs.
Figure 2. 
Pathways of cellular injury during freeing.
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1.3.2 DMSO-cryopreservation
DMSO has been used as an alternative for AM in glycerol-cryopreservation. 
An increasing concentration of DMSO is used instead of washing the AM with 
an antibiotic-saline solution after placenta collection [12]. Azuara-Blanco et al. 
[25] used 4%, 8%, and 10% DMSO, while Kubo et al. [26] used 0.5 M, 0.1 M, and 
0.15 M DMSO for washing. AMs can be stored in 10% or 0.15 M DMSO at −80°C 
for several months without significant damage. In general, solutions containing 
DMSO are used less often for AM cryopreservation compared to glycerol, due to 
high toxicity [12]. However, AM storage solutions containing DMSO have been 
studied a lot regarding its ability to increase cell viability in AM under experimental 
conditions [2].
A cryopreservation method with DMSO from Duan-Arnold’s group [24] showed 
a retained cell viability of over 80%. Cryopreserved AM tested after three months 
of storage showed no changes in the tissue architecture and collagen IV, which 
exists in the basement membrane, compared with fresh AM. However, in 2015, 
Yazdanpanah et al. [8] showed that the viability of epithelial cells in fresh AMs was 
estimated at 97% after staining with trypan blue, decreasing to about 50% in DMSO 
cryopreserved tissues after six months. They evaluated the effects of cryopreserva-
tion on AM angiogenesis modulation activity compared to fresh tissue in an animal 
model, showing that cryopreserved AM has the same effect on angiogenesis as fresh 
AM. The epithelial surface of cryopreserved AM inhibited angiogenesis, and the 
mesenchymal surface augmented vessel sprouting and length. In 2013, Tehrani et al. 
[27] used 10% DMSO as a cryoprotectant to evaluate the antibacterial properties of 
AM after preservation in vitro. The results of this study showed that the antibacte-
rial property of AM was maintained after cryopreservation, but was dependent on 
bacterial genus and strain.
To sum up, the literature we collected on DMSO-cryopreserved AM showed no 
significant differences in tissue integrity and biological properties (antibacterial 
and angiogenesis modulation) compared with fresh AM. However, although many 
research groups use DMSO as a cryoprotectant, the data related to cell viability vary. 
These conflicting results can be attributed to several factors, including differing 
cryopreservation procedures and storage times.
1.4 Controversy on cryopreserved AM
1.4.1 Variable cell viabilities
In 2000, Kruse et al. [18] believed that devitalized AM exhibited therapeutic 
effects, and their data showed that the preservation of viable cells in AM provided 
no additional benefits. This conclusion led to the development of cryopreserva-
tion methods including AM devitalization steps. One of them, known as the 
CRYOTEK® process, includes a freezing step before cryopreservation, resulting in 
devitalized tissue [28]. However, Yan et al. [29] demonstrated that the combination 
of exogenous cells and acellular AM resulted in faster wound closure compared with 
acellular AM alone. Duan-Arnold et al. [24] demonstrated that endogenous viable 
cells allow cryopreserved AM with higher angiogenic, anti-inflammatory, antioxi-
dant, fibroblast, and keratinocyte chemo-attractive activities when compared with 
AM in devitalization. Before 2001, most studies reported that cell viability of 50% 
or less at cryopreserved post-thaw with cells failing to survive after 18 months of 
storage at −80°C [26, 30]. Since then, scientists have been attempting to improve 
the cryopreservation method, for improved cell viability retention. For example, 
the cryopreservation protocol invented by the group of Duan Arnold et al. [24] 
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can maintain 70% or greater cell viability after 24 months of storage at −80°C. AM 
storage solutions containing dimethyl sulfoxide (DMSO) have been studied, mostly 
under experimental conditions, and shown the ability to increase AM cell viability 
[2]. Although the survival of amniotic cells is related to storage time, different 
cryopreservation steps can also affect cell viability, thus exerting different clinical 
effects.
1.4.2 Storage temperature
The best storage temperature (−196°C or − 80°C) is also a controversial issue 
for cryopreservation. AMs stored at −196°C have showed morphology similar to 
fresh AM in both preservation media, and AM stored at −80°C showed disruption 
of the stromal matrix [2, 31]. However, −80°C is still widely used by international 
scientists.
To sum up, cryopreservation protocols are not standardized. Preparation and 
sterilization before cryopreservation, as well as the selection of cryoprotectant dur-
ing cryopreservation, will lead to high variability in cell viability [2, 32]. Different 
storage temperature and storage time also affects the structure and function of 
amniotic membrane. It is important to establish adaptable protocols for the clini-
cal banking of AM that include verification of graft quality and viability before its 
release for transplantation, whether in the trial or clinical stage.
1.5 Commercially available cryopreserved AM
1.5.1 PROKERA®Slim (PKS)/PROKERA®(PK)
PROKERA®Slim (PKS) (Bio-Tissue, Inc., Miami, FL, USA) is a Class II medi-
cal device approved by the Food and Drug Administration in 2003 to be used as a 
temporary AM patch for delivering the biological actions of AM to a corneal surface 
without using sutures. It contains a piece of cryopreserved AM clipped into a 
concave poly-carbonate dual-ring system, like a symblepharon ring, that conforms 
to the corneal and limbal surface like a contact lens. The ring system has an inner 
diameter of 15 or 16 mm.
It has become the most common commercially available cryopreserved AM 
product in ophthalmology and is applied to various ocular surface and orbital disor-
ders. It is a safe and effective method that makes AM transplantation sutureless and 
adhesiveless, contributing to healing and reconstruction of the ocular surface and 
orbit with minimal side effects [33]. However, PROKERA is not recommended for 
eyes with functioning blebs or glaucoma drainage implants because of the opposi-
tional positioning of the retaining ring [34].
2. Cryopreservation of cornea
2.1 Introduction
Corneal disease is one of the world’s leading causes of blindness. Corneal scar-
ring and haze due to various factors can affect vision, making corneal transplanta-
tion an important means of treatment for corneal diseases [35–37]. Advances in 
corneal preservation techniques have improved the survival rate of corneal grafts 
[38] and have largely contributed to the development of modern corneal transplant 
surgery [39]. With the flourishing of corneal preservation technology, break-
throughs have been made in preservation times and corneal activity. Nevertheless, 
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cryopreservation is the only current method that can virtually preserve tissue 
structure for a long time.
Meanwhile, the development of modern eye banks have been accompanied by 
the advancement of corneal preservation technology. The establishment of an eye 
bank provides favorable conditions for corneal transplantation [40, 41].
2.2 Corneal transplantation and preservation
The idea of replacing the turbid cornea with transparent tissue was first pro-
posed by Pellier de Quengsy in 1789 [42, 43]. In 1824, Reisinger exploited animal 
corneas in surgery [44], which was named keratoplasty. Later in the nineteenth cen-
tury, a large number of animal experiments helped doctors realize that inter-species 
transplantation was a necessary condition to avoid corneal opacity after transplan-
tation [45–47]. In view of this, researchers began to experiment with human corneal 
transplantation. Early corneal transplantation relied on living donor tissues due to 
fears relating to transplanting dead tissue. The first successful full-thickness corneal 
transplantation (including all corneal layers) was completed in 1905 [48]. It was not 
until the 1930s that the cornea of the deceased donor was used and the entire eye 
was kept in a glass jug (wet room) for several days [49].
In 1912, Magitot reported that excised corneal grafts could be preserved in 
red blood cells at 5°C for eight days [50–52]. The grafts were successfully used 
for corneal lamellar transplantation [53]. At first, the freshness of the cornea was 
considered key to corneal transplantation [54, 55]. However, Ukrainian doctor 
Filatov systematically reported the application of corpus corneal tissue to clinical 
practice [56], which possessed an inter-generational meaning. It opened a new 
era of corneal preservation and transplantation [57–59]. These developments led 
to the establishment of the world’s first ophthalmology bank in New York in the 
1940s. The preservation technique of the original eye bank was very simple [60, 
61]: eyeballs were kept in a small glass bottle in a humid and cool environment [62]. 
Immediate removal of the eyeball after donor death was the only way to ensure the 
quality of the corneal grafts [63–65]. Eye banks were established in major cities, 
such as London, to guarantee that eyeballs were promptly forwarded [66, 67]. In 
the early 1950s, the activity of CECs was first considered as an important factor 
affecting transplantation [68–70]. The emphasis on preservation techniques was 
transferred to maintain the activity and integrity of CECs [71, 72]. Since then, 
corneal preservation techniques have been increasingly successful, resulting in 
approximately 40,000 corneal transplants per year in the United States, 20,000 per 
year in Europe, and thousands per year in other countries, such as India.
2.3 Corneal preservation methods
Corneal preservation is divided into two categories according to the survival of 
CECs: inactive and active preservation [73–75]. The former method includes dry 
preservation and cryopreservation [76–78] and operates under the principle of 
removing corneal moisture while inhibiting enzyme activity and autolysis in cells 
for long-term preservation [79, 80]. Common preservatives are glycerin, molecular 
sieves, and silica gel [81–83], which can preserve intact lamellar collagen structure 
[84]. Active preservation comprises short-term (hours to two days), medium-long 
term (7 to 30 days) and long-term (months to years) preservation. In terms of 
storage conditions, it utilizes normal (34~37°C), low (usually 4°C) and deep low 
(subzero) temperatures [85–88].
Short-term corneal storage mainly refers to the preservation of wet rooms, the 
simplest and most convenient of all corneal storage technologies. For this reason, 
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it is still the basic technology for preserving cornea in the eye banks of developing 
countries. As for medium-term corneal preservation, corneal preservation solution 
is stored at 4°C for 4 to 14 days [89].
The prolongation of corneal preservation allows more preparation for patients 
and flexible adjusting of operation times, while also satisfying blood test and 
corneal transportation times. With the improvement of preservation techniques, 
the composition of the corneal preservation solution has been constantly changing. 
A certain concentration of chondroitin sulfate is added to modify M-K solution, 
which can alleviate the swelling state during preservation. Optisol corneal medium 
preservation solution was proposed by Lindstrom and has become the most com-
mon preservation solution in US eye banks, which is mainly a mixture of K-liquid 
and Dexsol solution [90]. Long-term corneal preservation refers to organ culture 
storage and cryopreservation. Organ culture is to simulate the presence of a normal 
human cornea environment with medium at 30–37°C [91].
At present, there are several corneal preservation methods applied in global 
eye banks, but none of those is perfect. Each preservation method has its own 
advantages and disadvantages, which differ from the preservation temperature, 
the composition of the preservation solution, and the penetrant preventing matrix 
edema.
2.4 Cryopreservation
After donor death, the sudden stop of the aqueous humor causes nutrient and 
oxygen shortages, leading to final depletion at room temperature, which can, in 
turn, lead to autolysis of the corneal cells and initial damage to the cornea [92]. 
During the period from donor death to corneal removal and storage, the donor’s 
corpse is exposed to room temperatures, necessitating minimal time delays to 
ensure that the initial donor cornea is healthy and intact along with functional 
endothelial cells.
The acceptable short storage time, as well as organ damage, poses a logisti-
cal challenge to organ storage and ultimately affects grafts and patient survival. 
Prolonged storage times can cause many transplantable organs, further exacerbat-
ing the growing imbalance between organ supply and demand. Organ cryopreser-
vation is used to preserve long-lived cells and tissues. Theoretically, the storage of 
biological materials, including cells, tissues, and organs for transplantation at a 
low temperature (i.e., in liquid nitrogen at −160°C) is uncertain [93, 94]. Such a 
technique would have the potential to alter the way in which organs are recovered, 
distributed, and utilized for transplantation. However, ice is the biggest enemy in 
the cryopreservation of organs and tissues. Ice crystals, especially intracellular ice, 
can cause significant cellular damage and destroy the complex macroscopic tissues 
of intact organs. In this field, current developments are used to avoid the formation 
of ice, or mitigate it, during cryogenic storage. Any successful organ cryopreserva-
tion strategy requires a delicate balance between the relative needs of cryopreserva-
tion and toxicity in these situations.
2.5 Corneal cryopreservation technology
In 1954, Eastcott first adopted a cryopreserved human cornea for transplanta-
tion successfully [95, 96], pretreating the keratin tissue in glycerol before freezing 
it in a mixture of alcohol and carbon dioxide for cryopreservation of the full-thick-
ness cornea [97]. This method generally removes the cornea under the protection 
of a cryogen to −80°C, and stores it in liquid nitrogen at −196°C. Therefore, the 
CECs are in a dormant state. The state can completely inhibit the metabolism 
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of cells, eliminate the toxic effects caused by the accumulation of metabolites, 
and avoid the need to change the liquid during organ culture. In addition, it also 
restrains microorganisms during cryopreservation, protecting the cornea from 
microbial invasion.
The components currently contained in corneal cryoprotectants include DMSO, 
propylene glycol, ChS, and sucrose. DMSO is a relatively stable protective agent 
to maintain the integrity of corneal cells, while sucrose molecules act as buffers 
in corneal protection, and ChS improves CEC activity in cryopreservation [98]. 
DMSO began to be treated as a tissue preservative to preserve cultured rabbit 
CECs by Smith [99]. Shortly thereafter, Mueller injected a preservation solution 
containing DMSO into the anterior chamber of an eyeball, placing the eyeball in a 
preservation solution containing glycerol. The cornea was removed before surgery 
for full-thickness transplantation [100, 101]. In 1965, Capella [102] used DMSO as 
an antifreeze to improve a cryopreservation method, ensuring corneal graft activ-
ity. According to another report [103], the clinical application of cryopreservation 
techniques has little differences in techniques. The corneal tissue must be preserved 
eight hours after death. By increasing the level of DMSO, it eventually reaches a 
concentration of 7.5%. The classic four-step cooling is to initiate a cooling rate at 
1.5~2°C/min, drop the temperature to −30°C, change to 5–7°C/min, and ultimately 
maintain −80°C [104, 105].
It is still essential to further explore the rate of cooling to keep CEC activity and 
reduce cell loss [106, 107]. Temperature-controlled thawing before transplantation 
is a key step in protecting the corneal endothelium. At present, the prevalent view 
is that rapid rewarming could decrease the contact of cells with high concentra-
tions of electrolytes and reduce cell damage [108]. The thawing process of the 
cryopreserved cornea must be strictly controlled, as the solute containing DMSO 
has endotoxicity once the temperature exceeds 37°C [109]. Cryopreservation would 
impair the morphology and function of the corneal endothelium. During the thaw-
ing process, an ascending solute concentration, the formation of crystals, changes 
in pH, and osmotic pressure will reduce the survival rate of CECs [110]. Glycerol, 
polyvinylpyrrolidone, and DMSO can all be used as cryopreservatives, but DMSO is 
currently the most widely used [111, 112].
2.6 Effect of corneal cryopreservation
The ultra-low temperature preservation method overcomes the drawbacks of 
most other corneal preservation methods, significantly prolonging corneal preser-
vation time, reducing pollution, and avoiding the toxic effects of its own metabolic 
substances. Electron microscopy can observe changes in the subcellular morphology 
of CECs caused by cryopreservation, some of which are considered irreversible 
[113]. Studies have shown that, after cryopreservation, the barrier function of 
endothelial cells is impaired. Compared with wet room preservation and MK solu-
tion preservation, cryopreserved corneal grafts have been completely transparent 
for a long time after surgery. For one-year cryopreservation, 55% of endothelial 
cells were deactivated, while the rate of CECs preserved by MK solution was only 
21–22% [114]. There are barely significant structural differences in microbiological, 
histological, and ultrastructural features when comparing long-term cryopreserva-
tion of tissue (>7 years) and short-term cryopreserved cat corneal sclera (<1 year) 
[115]. As such, tissues cryopreserved for up to 10 years could be used for tectonic 
support without structural or microbial barriers.
Under suitable conditions, no crystal solidification occurs during the freezing 
process, called vitrification [116]. Vitrification requires a high concentration of 
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cryoprotectant, yet theoretically, tissue could be stored in a very low temperature 
environment without forming intracellular or extracellular crystals, and corneal 
endothelium damage could be avoided significantly [117]. Glycerol, 1,2-propane-
triol, and 2,3-butanediol are all considered as eligible cryopreservation agents for 
corneal vitrification [118, 119].
Studies have found that an effective concentration of a single cryopreservative 
is toxic to CECs, yet the mixture of preservatives or the addition of preservatives 
at low temperatures seems to reduce toxicity [120]. As a means of corneal pres-
ervation, further study is warranted to investigate whether vitrification would 
achieve good results. In 1981, Sperling used corneal grafts in a corneal preserva-
tion solution at the early stage and carried out a cryopreservation operation later. 
After rewarming, the cornea was transferred to a preservation solution, iden-
tifying corneal activity. The following studies indicated that the corneal grafts 
maintained transparency 71% of the time after 1 year and 58% of the time after 
12 years [121].
In our previous study, we performed lamellar keratoplasty combined with 
keratopigmentation in 22 corneal leukoma eyes using glycerol-cryopreserved 
corneal tissues, and no graft-rejection occurred during the 3 years of follow-up. 
Moreover, the outcome of a low graft rejection rate in glycerol-cryopreserved 
corneal tissues was also confirmed by our preceding study in treating Terrien mar-
ginal degeneration. In the subsequent study, for patients with refractive herpes 
simplex keratitis, 3 eyes of 27 eyes (11.1%) suffered allograft stromal rejection, all 
eyes reversed after prompt medication. Meanwhile, only 2 eyes (7.41%) exhibited 
refractive herpes simplex keratitis recurrence and the main site was located at the 
margin of the graft and the recipient bed. This result is consistent with the theory 
that grafts survive better when compared with reports clarifying that up to 33% 
of patients have suffered recurrence using fresh grafts. The recurrence rate in 
fresh grafts may be partially related to the long-term usage of topical steroid eye 
drops; however, it may be much more closely correlated with fewer keratocytes 
in the cryopreserved donor tissue to reactivate immune-inflammatory responses 
[122–124]. Based on the above information, glycerol-cryopreserved corneal tissues 
can be effectively and biosafely used with a low rejection and recurrence rate in 
corneal transplantation, especially in developing countries where good donor 
corneas are difficult to get.
3. Conclusion
The cryopreservation method can preserve the activity of the AM and cornea 
for extended periods up to several years, solving the problem of preservation time 
and activity deterioration. However, equipment complications, expensive techni-
cal support, and transport difficulties have become impediments to widespread 
use. The functional status of AM, endothelial cells, and corneal transparency have 
been of vital importance in the development of cryopreservation. As researchers 
become more aware of the function and properties of CECs, attempts to find a 
more conducive method and media for the preservation of AMs and corneas will 
continue.
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